Stocks Like Catalent and PerkinElmer Are Benefiting From Biotech’s ‘Gold Rush’ — Here’s Why

Beyond the catchy biotech names splashed across the headlines, experts say medical stocks in the background, like Catalent and PerkinElmer, are maybe more likely to strike it rich.

Investor’s Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market.

 

Don't miss a thing

Get free professional market insights and stock/ETF reports that contain actionable opportunities written by a former financial advisor and Capitalist who has been investing in the markets for 20+ years.

Scroll to Top